Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
International Journal of Biological Sciences|February 28, 2018
A Prognostic Model Based on Circulating Tumour Cells is Useful for Identifying the Poorest Survival Outcome in Patients with Metastatic Colorectal CancerWen-Chi Chou, Min-Hsien Wu, Pei-Hung Chang, et al.
Therapeutic Advances in Medical Oncology|January 22, 2024
Major adverse cardiovascular events in advanced-stage lung cancer: a multicenter cohort studyChih-Hao Chang, Shih-Hao Huang, Hung-Yu Huang, et al.
Cancers|March 13, 2024
Effect of Clinical Complete Remission Following Neoadjuvant Pembrolizumab or Chemotherapy in Bladder-Preservation Strategy in Patients with Muscle-Invasive Bladder Cancer Declining Definitive Local TherapyPei-Hung Chang, Hung-Yi Chen, Yueh-Shih Chang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 22, 2017
Glasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancerPei-Hung Chang, Cheng-Hsu Wang, Eric Yen-Chao Chen, et al.
Head & Neck|July 9, 2017
Impact of the pretreatment Glasgow prognostic score on treatment tolerance, toxicities, and survival in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapyPei-Hung Chang, Kun-Yun Yeh, Cheng-Hsu Wang, et al.
Oncology Letters|April 10, 2024
Circulating tumor cells help differentiate benign ovarian lesions from cancer before surgery: A literature review and proof of concept study using flow cytometry with fluorescence imagingYung-Chia Kuo, Chi-Hsi Chuang, Hsuan-Chih Kuo, et al.
NPJ Precision Oncology|August 30, 2025
Circulating miRNAs as potentially predictive biomarkers for chemoimmunotherapy in advanced biliary tract cancer: a post-hoc analysis of the phase II T1219 studyNai-Jung Chiang, Cheng-Yu Tang, Li-Yuan Bai, et al.
Oral Oncology|October 26, 2021
Whole-exome sequencing identifies biosignatures that predict adverse survival outcomes in surgically treated patients with oral cavity squamous cell carcinomaChun-Ta Liao, Lan-Yan Yang, Li-Yu Lee, et al.
Diagnostics (Basel, Switzerland)|March 12, 2020
Circulating Tumor Cells as a Tool of Minimal Residual Disease Can Predict Lung Cancer Recurrence: A longitudinal, Prospective TrialChing-Yang Wu, Chia-Lin Lee, Ching-Feng Wu, et al.
Oral Oncology|June 19, 2021
Both combined or sequential use with immune checkpoint inhibitors on cetuximab-treated patients with recurrent or metastatic head and neck squamous cell carcinoma improve the overall survivalMing-Yu Lien, Ti-Hao Wang, Ching-Yun Hsieh, et al.
Pageof 7